White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’
-
Jun 23, 2026, 6:20 pm138 ptsWhite House officials on Tuesday shot down a report speculating that President Trump gained access to the retatrutide weight-loss drug under the Food and Drug Administration’s (FDA) “compassionate use program.” The retatrutide drug is manufactured by Eli Lilly and is not FDA approved, however,…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.




